These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 7309322)
1. "Treatment of obesity by femoxetine a selective 5 HT reuptake inhibitor'. Smedegaard J; Christiansen P; Skrumsager B Int J Obes; 1981; 5(4):377-8. PubMed ID: 7309322 [No Abstract] [Full Text] [Related]
2. Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placebo. Bitsch M; Skrumsager BK Int J Obes; 1987; 11(2):183-90. PubMed ID: 3301710 [TBL] [Abstract][Full Text] [Related]
3. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo. Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446 [TBL] [Abstract][Full Text] [Related]
4. So-called "tension headache"--the response to a 5-HT uptake inhibitor: femoxetine. Sjaastad O Cephalalgia; 1983 Mar; 3(1):53-60. PubMed ID: 6850822 [TBL] [Abstract][Full Text] [Related]
5. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Andersson PG; Petersen EN Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183 [TBL] [Abstract][Full Text] [Related]
6. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Kangasniemi PJ; Nyrke T; Lang AH; Petersen E Acta Neurol Scand; 1983 Oct; 68(4):262-7. PubMed ID: 6606930 [TBL] [Abstract][Full Text] [Related]
7. Reduction of whole blood serotonin in depressed patients treated with a new, selective serotonin-uptake inhibitor, femoxetine. Børup C; Petersen IM; le Fèvre Honoré P; Wetterberg L Psychopharmacology (Berl); 1979 Jun; 63(3):241-3. PubMed ID: 113809 [TBL] [Abstract][Full Text] [Related]
9. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression. Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of obesity in general practice with femoxetine. A controlled clinical trial of the effects of femoxetine and placebo]. Kristensen JS; Christiansen P; Skrumsager BK Ugeskr Laeger; 1982 Mar; 144(13):939-42. PubMed ID: 7048680 [No Abstract] [Full Text] [Related]
11. Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetine. Dalsgaard-Nielsen J; le Fèvre Honoré P; Zeeberg I Acta Neurol Scand; 1982 Aug; 66(2):191-8. PubMed ID: 6982585 [TBL] [Abstract][Full Text] [Related]
12. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison. Skrumsager BK; Jeppesen K Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871 [TBL] [Abstract][Full Text] [Related]
13. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI). J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815 [No Abstract] [Full Text] [Related]
16. Targeting 5-HT receptors for the treatment of obesity. Sargent BJ; Henderson AJ Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209 [TBL] [Abstract][Full Text] [Related]
17. Clinical overview of serotonin reuptake inhibitors. Rickels K; Schweizer E J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study. Suominen J; Tamminen T; Elosuo R; Manniche PM Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246 [TBL] [Abstract][Full Text] [Related]
19. An early clinical phase II evaluation of paroxetine, a new potent and selective 5HT-uptake inhibitor in patients with depressive illness. Børup C; Meidahl B; Petersen IM; Vangtorp A; le Fèvre Honoré P Pharmacopsychiatria; 1982 Nov; 15(6):183-6. PubMed ID: 6218507 [TBL] [Abstract][Full Text] [Related]
20. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. Tulloch IF; Johnson AM J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]